During the past decade, Gabinet Kardiologiczno-Internistyczny conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gabinet Kardiologiczno-Internistyczny" #1 collaborator was "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Gabinet Kardiologiczno-Internistyczny" are "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Cardiovascular Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "High Cardiovascular Risk" (1 trials). Many other conditions were trialed in "Gabinet Kardiologiczno-Internistyczny" in a lesser frequency.

Most popular intervention types in "Gabinet Kardiologiczno-Internistyczny" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apabetalone" (1 trials), "Atorvastatin" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "Lorcaserin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gabinet Kardiologiczno-Internistyczny" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Gabinet Kardiologiczno-Internistyczny". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Gabinet Kardiologiczno-Internistyczny, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gabinet Kardiologiczno-Internistyczny, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".